While more work needs to be done to address the discrepancies, the consensus seems to be that AhR antagonism would be beneficial to promote a tumor-suppressive microenvironment and relieve the immune-suppression often seen associated with the more aggressive tumors. Here, AHR is linked to neoplasm.